Celgene

- NASDAQ:CELG
Last Updated 2020-01-16
  • Celgene: A Global Biopharmaceutical Company Committed to Improving the Lives of Patients Worldwide with Innovative and Life-Changing Treatments
  • Locations

    • 100 Macy St Unit F174, Amesbury MA
    • Summit NJ
  • Acquisitions (11)

    • Celgene (2019)
    • Juno Therapeutics (2018)
    • Impact Biomedicines (2018)
    • Delinia (2017)
    • Anokion (2017)
    • Acetylon Pharmaceuticals (2016)
    • EngMab (2016)
    • Receptos (2015)
    • Quanticel Pharmaceuticals (2015)
    • Avila Therapeutics (2012)
    • Abraxis BioScience (2010)
  • Security

    Type: ORD
    CUSIP: 151020104
    ISIN: US1510201049
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo 2019-09-24
Filter date
All
Article Author Published
Job posting data foreshadows big pharma deals Jon Marino 2019-06-10
Mega M&A means job postings vanish at Fortune 500 companies Jon Marino 2019-05-31

Request a demo to view additional historical data, and much more.